Health Catalyst, Inc

Historical 13F Holders

Symbol
HCAT
CUSIP
42225T107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 42225T107 since 12/18/2024, newest first.

Filer % of Class Filed
Palogic Value Management, L.P. 13D/A Amendment 1
7.1% 9/8/2026
Event 9/4/2026
Stoney Lonesome HF LP 13G/A Amendment 2
9.6% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 3 1.5% 7/28/2026
Event 6/30/2026
Impax Asset Management Group plc 13G
5.4% 7/21/2026
Event 6/30/2026
Palogic Value Management, L.P. 13D
6.7% 6/22/2026
Event 6/12/2026
Whetstone Capital Advisors, LLC 13D/A Amendment 2
4.5% 6/8/2026
Event 6/4/2026
Stoney Lonesome HF LP 13G/A Amendment 1
8.6% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 8 0% 3/27/2026
Event 3/13/2026
First Light Asset Management, LLC 13D/A Amendment 1
18.3% 3/13/2026
Event 3/12/2026
Whetstone Capital Advisors, LLC 13D/A Amendment 1
8.2% 2/18/2026
Event 2/17/2026
Whetstone Capital Advisors, LLC 13D
7.4% 1/21/2026
Event 1/15/2026
Whetstone Capital Advisors, LLC 13G/A Amendment 1
5.3% 1/14/2026
Event 12/31/2025
Stoney Lonesome HF LP 13G
5.5% 12/22/2025
Event 12/15/2025
First Light Asset Management, LLC 13D
19.7% 12/3/2025
Event 12/1/2025
First Light Asset Management, LLC 13G/A Amendment 3
19.8% 11/14/2025
Event 9/30/2025
Whetstone Capital Advisors, LLC 13G
5.4% 9/8/2025
Event 6/30/2025
First Light Asset Management, LLC 13G/A Amendment 2
17.2% 5/13/2025
Event 5/7/2025
Vanguard Group Inc 13G/A Amendment 7 5.9% 4/30/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 2 6.3% 4/17/2025
Event 3/31/2025
First Light Asset Management, LLC 13G/A Amendment 1
11.8% 2/7/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 71.6 k $124 k
2026 Q2 138 57.2 M $114 M
2026 Q1 143 55.8 M $70.9 M
2025 Q4 141 55.3 M $132 M
2025 Q3 150 54.9 M $157 M
2025 Q2 150 54.2 M $204 M
2025 Q1 173 53.2 M $241 M
2024 Q4 177 51.9 M $376 M
2024 Q3 169 53.3 M $434 M
2024 Q2 169 52.6 M $336 M
2024 Q1 183 52.0 M $392 M
2023 Q4 174 52.7 M $488 M
2023 Q3 166 49.4 M $500 M
2023 Q2 160 48.8 M $610 M
2023 Q1 168 48.6 M $568 M
2022 Q4 177 50.2 M $534 M
2022 Q3 187 50.1 M $486 M
2022 Q2 188 52.9 M $767 M
2022 Q1 195 53.3 M $1.39 B
2021 Q4 199 55.7 M $2.20 B
2021 Q3 213 53.9 M $2.70 B
2021 Q2 213 48.7 M $2.71 B
2021 Q1 204 44.5 M $2.08 B
2020 Q4 181 40.5 M $1.76 B
2020 Q3 151 40.0 M $1.46 B
2020 Q2 136 34.0 M $991 M
2020 Q1 115 28.2 M $736 M
2019 Q4 93 23.5 M $815 M
2019 Q3 89 16.7 M $523 M